pyrazole has been researched along with 2,4-thiazolidinedione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, MJ; Alam, MM; Alam, O; Naidu, VGM; Naim, MJ; Shaquiquzzaman, M | 1 |
| Bansal, G; Chawla, P; Monga, V; Singh, S; Thanikachalam, PV | 1 |
2 other study(ies) available for pyrazole and 2,4-thiazolidinedione
| Article | Year |
|---|---|
Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators.
Topics: 3T3-L1 Cells; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; HEK293 Cells; Humans; Hypoglycemic Agents; Mice; Molecular Docking Simulation; Molecular Structure; PPAR gamma; Pyrazoles; Rats; Streptozocin; Structure-Activity Relationship; Thiazolidinediones | 2018 |
Synthesis and biological evaluation of thiazolidine-2,4-dione-pyrazole conjugates as antidiabetic, anti-inflammatory and antioxidant agents.
Topics: alpha-Amylases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood Glucose; Dose-Response Relationship, Drug; Hypoglycemic Agents; Interleukin-1beta; Malondialdehyde; Mice; Mice, Inbred C57BL; Molecular Docking Simulation; Molecular Structure; PPAR gamma; Pyrazoles; Structure-Activity Relationship; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2019 |